Evaluation of Improved Onboard Patient Imaging

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Head and Neck CancerBreast CancerUpper Gastrointestinal CancerLung CancerPelvic Cancer
Interventions
DEVICE

HyperSight Imaging

Patients receive standard of care radiation treatment on a Varian TrueBeam system equipped with HyperSight CBCT imaging. Images acquired for daily patient positioning from two different treatment fractions - typically one near the beginning of the treatment course and one at about the halfway point - will be analyzed for the study.

Trial Locations (1)

21201-1544

RECRUITING

University of Maryland Medical Center, Baltimore

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY

NCT06187103 - Evaluation of Improved Onboard Patient Imaging | Biotech Hunter | Biotech Hunter